Senior insider sale
Vice President, Finance at CYMABAY THERAPEUTICS, INC. — senior position signals high conviction
$2.67M
119K shares
What this filing means
MENOLD DANIEL plans to sell 119K shares of CYMABAY THERAPEUTICS, INC. valued at approximately $2.67M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/29/2024ACC: 0001972362-24-000050
Officer· Vice President, Finance
Since Aug 2018
119K
Shares to sell
$2.67M
Approx. market value
50K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
1/29/2024
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/29/2024 | STOCK OPTION EXERCISE COMPENSATION | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
20K
Market value
$460.8K
1/26/2024
—Completed
Units to sell
10K
Market value
$235.8K
1/16/2024
—Completed
Units to sell
21.50K
Market value
$472.6K
12/15/2023
—Completed
Units to sell
17.50K
Market value
$304.1K
11/15/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$1.20M
1/29/2024
Total
Units
119K
Value
$2.67M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2024 | 20K | $460.8K | — | Completed |
1/16/2024 | 10K | $235.8K | — | Completed |
12/15/2023 | 21.50K | $472.6K | — | Completed |
11/15/2023 | 17.50K | $304.1K | — | Completed |
| Planned — Approximate Date | ||||
1/29/2024 | 50K | $1.20M | NASDAQ | Planned |
| Total | 119K | $2.67M | ||